Presentatie Gosens op Europese schouder en elleboog congres in Lyon

Vanuit het St. Elisabeth ziekenhuis was er active deelname aan het Europese schouder en elleboog congres in Lyon. Er werd aan Taco Gosens een podium geboden de resultaten te presenteren van een onderzoek welke in samenwerking met het HAGA ziekenhuis in Den Haag werd uitgevoerd. Het betrof het effect van steroid of PRP injecties bij de chronische tenniselleboog.

Zoals eerder in deze weblog vermeld zijn de 2 jaars resultaten beter dan de 1 jaars resultaten en is er zelfs mbt de kosten een winst ten faveure van de PRP groep doordat er operaties kunnen worden voorkomen.

Ongoing Positive Effect of Platelet Rich Plasma in Lateral Epicondylitis

T Gosens , JC Peerbooms, W van Laar, B Den Oudsten (Tilburg - NETHERLANDS)

Purpose

Platelet Rich Plasma (PRP) has shown to be a general stimulation for repair and 1 year results showed promising success percentages.

Material and Methods

A double-blind randomized controlled trial was conducted between May 2006 and January 2008. 100 patients with chronic lateral epicondylitis were randomly assigned to a leucocyte-enriched PRP group (n = 51) or in the corticosteroid group (n = 49). Randomization and allocation to the trial group were carried out by a central computer system. The primary analysis included Visual Analogue Scale (VAS) pain scores and Disabilities of the Arm, Shoulder, and Hand Outcome (DASH) scores.

Results

The PRP group was more often successfully treated than the corticosteroid group (p<.0001). Success was defined as a reduction of 25% on VAS or DASH scores without a re-intervention after 2 years. When baseline VAS and DASH scores were compared with the scores at 2 years follow-up, both groups significantly improved across time. However, the DASH scores of the corticosteroid group returned back to baseline levels, while the PRP significantly improved. There were no complications related to the use of PRP.

Conclusion

Treatment of patients with chronic lateral epicondylitis with PRP reduces pain and increases function significantly, exceeding the effect of corticosteroid injection even after a follow-up of two years. Future decisions for application of PRP for lateral epicondylitis should be confirmed by further follow-up from this trial and should take into account possible costs and harms as well as benefits.